20
Participants
Start Date
September 6, 2017
Primary Completion Date
December 12, 2019
Study Completion Date
December 12, 2019
Injection of autologous fatty tissue associated with autologous platelet-rich plasma.
Patients will receive 2 separate infiltrations for three months by intra and subdermal injection of autologous fatty tissue (20cc) associated with autologous platelet-rich plasma (4cc) in each half vulvar.
Corticosteroids (clobetasol 0.05%)
Patients will receive a maintenance treatment of topical therapy with corticosteroids (clobetasol 0.05%) that will be administered by usual clinical practice.
Hospital Universitario y Politécnico La Fe, Valencia
Instituto de Investigacion Sanitaria La Fe
OTHER